The elevated expression of PAR2 in RA patient synovial cells, its contribution to IL-1β secretion in synovial fluid, and its role in bone remodeling highlight its significance in RA pathogenesis and its potential as a therapeutic target [67,68]. The gene discussed is NR1I2; the disease is rheumatoid arthritis.